alovudine has been researched along with Sensitivity and Specificity in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 39 (58.21) | 29.6817 |
2010's | 27 (40.30) | 24.3611 |
2020's | 1 (1.49) | 2.80 |
Authors | Studies |
---|---|
Eimer, S; Fernandez, P; Gimbert, E; Lamare, F; Ledure, S; Loiseau, H; Monteil, P; Penchet, G; Perez, P; Tourdias, T; Vimont, D; Zanotti-Fregonara, P | 1 |
Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
Kuang, A; Ma, H; Pang, F; Ren, P; Shen, G | 1 |
Broccoli, A; Fanti, S; Fonti, C; Lambertini, A; Lodi, F; Nanni, C; Pellegrini, C; Stefoni, V; Zanoni, L; Zinzani, PL | 1 |
Fatema, CN; Kitagawa, Y; Kuge, Y; Murakami, M; Nishijima, K; Tamaki, N; Yu, W; Zhao, S; Zhao, Y | 1 |
Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
Chen, Y; Liu, B; Qu, B; Tian, J; Wang, H; Xu, B; Zhang, J | 1 |
Benci, JL; Chandrasekaran, S; Davis, JJ; Dorsey, JF; Hollander, A; Kao, G; Xu, X | 1 |
Bejot, R; Bhakoo, KK; Goggi, JL; Moonshi, SS | 1 |
Aide, N; Berriolo-Riedinger, A; Blagosklonov, O; Brenot-Rossi, I; Bridji, B; Cachin, F; Caignon, JM; Chaumet-Riffaud, P; Collombier, L; Courbon, F; Devillers, A; Doyeux, K; Dubray, B; Fernandez, P; Gremillet, E; Houzard, C; Kolesnikov-Gauthier, H; Modzelewski, R; Olivier, P; Roux, J; Tessonnier, L; Thureau, S; Vera, P; Vervueren, L | 1 |
Bussink, J; Hoeben, BA; Kaanders, JH; Oyen, WJ; Troost, EG; van Herpen, CM | 1 |
Cheng, X; Navab, N; Shi, K; Ziegler, SI | 1 |
Kuo, WH; Shih, TT; Wang, J; Yen, RF | 1 |
Adler, S; Choyke, PL; Kurdziel, KA; Lindenberg, ML; Logan, J; Mena, E; Shih, J; Turkbey, BI; Wilson, W; Wong, K | 1 |
Boellaard, R; Chamuleau, ME; Cillessen, SA; Hoekstra, OS; Hoetjes, N; Jauw, Y; Regelink, JC; Rizvi, SN; van de Ven, PM; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
Carlson, ER; Heidel, RE; Schaefferkoetter, JD | 1 |
Małkowski, B; Śrutek, E; Staniuk, T; Szlęzak, P; Zegarski, W | 1 |
Jinguji, M; Kajiya, Y; Nakajo, M; Tani, A; Yoshiura, T | 1 |
Bayouth, JE; Bhatia, SK; Buatti, JM; Graham, MM; Gross, BA; Jacobson, GM; McGuire, SM; Menda, Y; Ponto, LL; Smith, BJ; Sun, W; Sunderland, JJ | 1 |
Eguchi, A; Kataoka, Y; Kume, S; Nakano, M; Takahashi, K; Takata, K; Tamura, Y; Watanabe, Y; Yamato, M | 1 |
Bag, AK; Desai, AS; Desideri, S; Fisher, JD; Grossman, SA; Holdhoff, M; Leal, JP; Lesser, GJ; Lieberman, FS; Lodge, MA; Mankoff, DA; Mintz, A; Mountz, JM; Nabors, LB; Schiff, D; Wahl, RL; Ye, X | 1 |
Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
Aigbirhio, FI; Burnet, NG; Clark, JC; Cleij, MC; Dean, AF; Fryer, TD; Gillard, JH; Hutchinson, PJ; Joseph, J; Pickard, JD; Price, SJ; Salvador, R; Wang, DD | 1 |
Han, DL; Jiang, WR; Yu, JM | 1 |
Buck, AK; Eckel, F; Herrmann, K; Hillerer, C; Krause, BJ; Langer, R; Schmid, RM; Schmidt, S; Schuster, T; Schwaiger, M; Wester, HJ; Wieder, HA | 1 |
Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF | 1 |
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
Aide, N; Cullinane, C; Dorow, D; Hicks, RJ; Kinross, K; McArthur, G; Neels, O; Roselt, P; Waldeck, K | 1 |
Krause, BJ; Lordick, F; Ott, K | 1 |
Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X | 1 |
Beer, AJ; Buck, AK; Dobritz, M; Erkan, M; Friess, H; Herrmann, K; Kleeff, J; Schmid, RM; Schuster, T; Schwaiger, M; Siveke, JT; Wester, HJ | 1 |
Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 2 |
Faria, M; Halquist, MS; Karnes, HT; Kindt, E; Li, W; O'Brien, PJ | 1 |
Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M | 1 |
Arulampalam, TH; Costa, DC; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Townsend, C; Visvikis, D | 1 |
Bares, R; Dittmann, H; Dohmen, BM; Eichhorn, K; Eschmann, SM; Horger, M; Machulla, HJ; Paulsen, F; Wehrmann, M | 1 |
Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kotzerke, J; Mattfeldt, T; Neumaier, B; Reske, SN; Schirrmeister, H; Wurziger, I | 1 |
Shields, AF | 1 |
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ | 1 |
Bares, R; Dittmann, H; Dohmen, BM; Fersis, N; Machulla, HJ; Reischl, G; Smyczek-Gargya, B; Vogel, U; Wallwiener, D | 1 |
Dence, C; Kim, J; Oyama, N; Ponde, DE; Tai, YC; Welch, MJ | 1 |
Cobben, DC; de Vries, EF; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van Waarde, A | 1 |
Costa, DC; Croasdale, I; Ell, PJ; Francis, D; Luthra, SK; Mulligan, R; Taylor, I; Visvikis, D | 1 |
Cobben, DC; Elsinga, PH; Groen, HM; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W | 1 |
Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kratochwil, C; Mattfeldt, T; Möller, P; Mottaghy, FM; Neumaier, B; Reske, SN; Schirrmeister, H; Wahl, A | 1 |
Grierson, JR; Krohn, KA; Mankoff, DA; Muzi, M; Peterson, L; Schmidt, RA; Vesselle, H; Wells, JM | 1 |
Grierson, JR; Krohn, KA; Mankoff, DA; Muzi, M; Vesselle, H; Wells, JM | 1 |
Choi, SJ; Kim, CJ; Kim, JH; Kim, JS; Lee, JG; Moon, DH; Oh, SJ; Ra, YS; Ryu, JS; Yeo, JS | 1 |
Cobben, DC; Elsinga, PH; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL; Wesseling, J | 1 |
Carrió, I; Ell, PJ; Pakzad, F | 1 |
Campone, M; Carlier, T; Chatal, JF; Couturier, O; Hustinx, R; Leost, F | 1 |
Cheng, Z; Dandekar, M; Gambhir, SS; Louie, S; Park, JM; Subbarayan, M; Tseng, JR | 1 |
Dittmar, C; Galldiks, N; Garlip, G; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Klein, JC; Kracht, LW; Li, H; Sobesky, J; Thomas, A; Vollmar, S; Wienhard, K | 1 |
Cheon, GJ; Cho, KJ; Im, KC; Kim, SY; Lee, H; Lee, SW; Moon, DH; Oh, SJ; Ryu, JS; Yang, YJ | 1 |
Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P | 1 |
Cameron, RB; Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Weber, WA; Yap, CS | 1 |
Araki, N; Hashimoto, N; Higashi, T; Hiraoka, M; Hojo, M; Kawashima, H; Manabe, T; Mukai, T; Nakashima, Y; Oya, N; Saga, T; Takahashi, JA; Togashi, K | 1 |
Buck, AK; Neumaier, B; Reske, SN; Schmid, M; Vogg, AT; Wczasek, K; Zlatopolskiy, BD | 1 |
Hicks, RJ | 1 |
Bandoh, S; Chang, SS; Haba, R; Ishikawa, S; Kanaji, N; Kushida, Y; Nakano, J; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
Barbet, J; Bourgeois, M; Cherel, M; Faivre-Chauvet, A; Gestin, JF; Le Bars, D; Leost, F; Mougin-Degraef, M | 1 |
Brockenbrough, JS; Grierson, JR; Jordan, R; Rasey, JS; Schwartz, JL; Vesselle, H; Wiens, LW | 1 |
Asakura, M; Bandoh, S; Ishikawa, S; Kanaji, N; Kimura, N; Nishiyama, Y; Ohkawa, M; Okuda, M; Yamamoto, Y | 1 |
Chang, ST; Chin, F; Dick, DW; Gambhir, SS; Kamaya, A; Koong, AC; Loo, BW; Quon, A | 1 |
Alauddin, MM; Bornmann, W; Gelovani, JG; Mawlawi, O; Mukhopadhyay, U; Nishii, R; Pal, A; Volgin, AY | 1 |
Chen, P; Feng, H; Ma, L; Tan, Y; Tian, J; Wu, W; Xin, J; Yang, X; Yu, L; Zhao, Z | 1 |
5 review(s) available for alovudine and Sensitivity and Specificity
Article | Year |
---|---|
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysis.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2018 |
[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
Topics: Dideoxynucleosides; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Is 3'-deoxy-3'- [18F] fluorothymidine ([18F]-FLT) the next tracer for routine clinical PET after R [18F]-FDG?].
Topics: Animals; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
16 trial(s) available for alovudine and Sensitivity and Specificity
Article | Year |
---|---|
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Misonidazole; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.
Topics: Adult; Aged; Chemoradiotherapy; Dideoxynucleosides; Female; Hematologic Diseases; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiation Protection; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[18F]FLT PET for diagnosis and staging of thoracic tumours.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed | 2003 |
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Statistics as Topic; Tomography, Emission-Computed | 2003 |
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiography; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting | 2004 |
Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Clinical relevance of imaging proliferative activity in lung nodules.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule | 2005 |
Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Dideoxynucleosides; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lung Neoplasms; Metabolic Clearance Rate; Models, Biological; Neoplasm Invasiveness; Neoplasm Staging; Organ Specificity; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2005 |
[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Feasibility Studies; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
Topics: Aged; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
46 other study(ies) available for alovudine and Sensitivity and Specificity
Article | Year |
---|---|
Combining 3'-Deoxy-3'-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection.
Topics: Adult; Aged; Biological Transport; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tumor Burden | 2019 |
Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Dideoxynucleosides; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
The value of 18F-FLT PET for detecting second primary cancers and distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Evaluation of ¹⁸F-FDG and ¹⁸F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Female; Glioblastoma; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2013 |
Stratification of 18F-labeled PET imaging agents for the assessment of antiangiogenic therapy responses in tumors.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Imidazoles; Indazoles; Isotope Labeling; Mice; Neoplasms, Experimental; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Direct parametric image reconstruction of rapid multi-tracer PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Models, Biological; Neoplasms, Experimental; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Using (18)F-FLT PET to distinguish between malignant and benign breast lesions with suspicious findings in mammography and breast ultrasound.
Topics: Adult; Aged; Breast; Breast Neoplasms; Dideoxynucleosides; Female; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prone Position; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed; Ultrasonography, Mammary; Whole Body Imaging | 2014 |
A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of FLT-PET/CT and CECT in gastric cancer diagnosis.
Topics: Aged; Contrast Media; Dideoxynucleosides; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging.
Topics: Animals; Antidepressive Agents; Brain; Cell Proliferation; Depression; Dideoxynucleosides; Image Enhancement; Male; Neurogenesis; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Repeatability of
Topics: Adult; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; United States | 2017 |
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2009 |
Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Mapping; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
Topics: Aged; Algorithms; Carcinoma, Hepatocellular; Dideoxynucleosides; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Disease Models, Animal; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate.
Topics: Carcinoma, Hepatocellular; Case-Control Studies; Chromatography, High Pressure Liquid; Dideoxynucleosides; Drug Stability; Female; Humans; Linear Models; Liver Neoplasms; Male; Middle Aged; Phosphorylation; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thymidine Kinase; Thymidine Monophosphate | 2012 |
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured | 2002 |
PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.
Topics: Animals; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasm Staging; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymidine | 2003 |
3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Topics: Adult; Aged; Bone Marrow Neoplasms; Dideoxynucleosides; False Negative Reactions; False Positive Reactions; Feasibility Studies; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Topics: Androgens; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dideoxynucleosides; Diethylstilbestrol; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Inflammation; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Rodentia; Sensitivity and Specificity; Tissue Distribution; Turpentine | 2004 |
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.
Topics: Algorithms; Cell Proliferation; Computer Simulation; Dideoxynucleosides; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Neoplasm Staging; Neoplasms; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2005 |
Molecular imaging in animal models of disease--every little detail counts!
Topics: Animals; Artifacts; Dideoxynucleosides; Dogs; Humans; Mice; Molecular Probe Techniques; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity; Species Specificity; Tissue Distribution | 2005 |
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
Topics: Animals; Cell Line, Tumor; Dideoxynucleosides; Female; Glioma; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity | 2005 |
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Topics: Adult; Aged; Antiviral Agents; Astrocytoma; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; False Positive Reactions; Female; Glioma; Humans; Kinetics; Magnetic Resonance Imaging; Male; Medulloblastoma; Methionine; Middle Aged; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2005 |
Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Male; Mice; Mice, Inbred C3H; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2006 |
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms | 2006 |
Evaluation of primary brain tumors with FLT-PET: usefulness and limitations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Child; Dideoxynucleosides; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT.
Topics: Animals; Cell Line, Tumor; Deoxyuridine; Dideoxynucleosides; Drug Evaluation, Preclinical; Humans; Isotope Labeling; Lymphoma; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2007 |
The SUV and FLT PET: a tasty alphabet soup or a dog's breakfast?
Topics: Combined Modality Therapy; Data Interpretation, Statistical; Dideoxynucleosides; Disease-Free Survival; Humans; Lymphoma; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2007 |
Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
Purification of [18F]-fluoro-L-thymidine ([18F]-FLT) for positron emission tomography imaging.
Topics: Calibration; Chromatography, High Pressure Liquid; Dideoxynucleosides; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.
Topics: Cell Line, Tumor; Dideoxynucleosides; Enzyme Activation; Humans; Metabolic Clearance Rate; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymidine Phosphorylase; U937 Cells | 2007 |
Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
Topics: Animals; Arabinofuranosyluracil; Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, X-Ray Computed | 2008 |